Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
platelet-rich plasma + betamethasone
- Development stage
- Unknown
- Lead developer
- University of Kyrenia
- Modality
- Cell Therapies, Small Molecules
- Administration
- Intramuscular
01
Overview
Platelet-rich plasma + betamethasone is a combination therapy being investigated for the treatment of musculoskeletal conditions, specifically myofascial pain syndrome (MPS). Platelet-rich plasma (PRP) is an autologous blood product containing a high concentration of platelets, which release various growth factors such as platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF) to promote tissue healing and cellular proliferation. Betamethasone is a potent synthetic corticosteroid that acts as a glucocorticoid receptor agonist, providing rapid anti-inflammatory and immunosuppressive effects. The combination aims to leverage the immediate pain relief provided by the steroid with the regenerative potential of PRP for long-term recovery. It is typically administered via trigger point injection, often in conjunction with a local anesthetic like bupivacaine.
- Other names
- PRP plus BetamethasonePRP + betamethasone
02
Targets
IGF-1R (Insulin-like growth factor 1 receptor)TGFBR (TGF-beta receptor)EGFR (Epidermal growth factor receptor)GR (Glucocorticoid receptor)PDGFRA (Platelet-derived growth factor receptor alpha)
Beyond the preview
Go deeper on platelet-rich plasma + betamethasone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on platelet-rich plasma + betamethasone.